![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
0
USA (Orange Book)
Europe
0
Canada
0
Australia
South Africa
0
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
Details:
Sculptra is the first and original injectable collagen stimulator containing microparticles of unique poly-L-lactic acid (PLLA-SCA) which gradually revitalizes the skin’s structural foundation.
Lead Product(s): L-Lactic Acid,Sodium Carboxymethylcellulose
Therapeutic Area: Dermatology Product Name: Sculptra
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable March 30, 2023
Details:
The Consumer Health business primarily consists of the following over-the-counter brands: TheraTears , Diabetic Tussin , MagOx , Multi-betic , and Zostrix.
Lead Product(s): Sodium Carboxymethylcellulose
Therapeutic Area: Ophthalmology Product Name: TheraTears
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Prestige Consumer Healthcare
Deal Size: $230.0 million Upfront Cash: $230.0 million
Deal Type: Divestment May 27, 2021